Name
Eesti Chem OÜ
Registry code
11183216
VAT number
EE101095231
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.11.2005 (19)
Financial year
01.01-31.12
Capital
23 200.00 €
Activity
52291 - Forwarding agencies services
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Osaühing Havila 10858899 | 100% - 23 200.00 EUR | - | - | |
| Igor Lepetukhin 29.12.1945 (78) | - | Board member | Direct ownership | Founder |
| Nikolai Grigorev 20.02.1984 (40) | - | Board member | - |
| 2019 03.12.2020 | 2020 30.09.2021 | 2021 31.08.2022 | 2022 22.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 7 636 988 € | 8 053 647 € | 7 588 419 € | 7 755 522 € |
| Net profit (loss) for the period | -202 116 € | -106 993 € | 171 729 € | -100 271 € |
| Profit Margin | -3% | -1% | 2% | -1% |
| Current Assets | 1 833 476 € | 2 333 015 € | 3 148 240 € | 3 025 017 € |
| Fixed Assets | 335 562 € | 306 135 € | 271 334 € | 252 073 € |
| Total Assets | 2 169 038 € | 2 639 150 € | 3 419 574 € | 3 277 090 € |
| Current Liabilities | 1 072 797 € | 1 556 475 € | 1 892 676 € | 2 120 463 € |
| Non Current Liabilities | - | - | 270 000 € | 0 € |
| Total Liabilities | - | - | 2 162 676 € | - |
| Share Capital | - | - | - | - |
| Equity | 1 096 241 € | 1 082 675 € | 1 256 898 € | 1 156 627 € |
| Employees | 12 | 12 | 10 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 953 749.24 € | 55 390.75 € | 40 941.97 € | 5 |
| 2023 Q4 | 2 312 789.48 € | 57 116.05 € | 42 335.94 € | 5 |
| 2023 Q3 | 2 287 573.08 € | 77 917.64 € | 75 048.27 € | 5 |
| 2023 Q2 | 3 147 639.45 € | 44 260.52 € | 45 501.7 € | 5 |
| 2023 Q1 | 3 341 893.53 € | 34 818.3 € | 35 954.31 € | 5 |
| 2022 Q4 | 3 784 279.22 € | 31 421.38 € | 33 075.89 € | 5 |
| 2022 Q3 | 2 993 532.22 € | 30 632.39 € | 32 145.75 € | 5 |
| 2022 Q2 | 2 825 334.13 € | 32 856.55 € | 34 190.86 € | 5 |
| 2022 Q1 | 2 118 655.06 € | 33 603.84 € | 35 421.85 € | 6 |
| 2021 Q4 | 3 157 820.51 € | 34 502.96 € | 36 497.26 € | 6 |
| 2021 Q3 | 2 501 500.87 € | 48 412.12 € | 50 606.38 € | 6 |
| 2021 Q2 | 2 330 104.66 € | 42 597.94 € | 43 473.18 € | 6 |
| 2021 Q1 | 2 366 291.57 € | 31 379.81 € | 33 110.49 € | 8 |
| 2020 Q4 | 2 295 684.92 € | 30 456.47 € | 32 342.85 € | 8 |
| 2020 Q3 | 2 824 567.58 € | 32 357.86 € | 34 347.12 € | 8 |
| 2020 Q2 | 3 270 488.02 € | 36 039.84 € | 36 868.5 € | 8 |
| 2020 Q1 | 1 847 136.58 € | 34 237.79 € | 36 338.59 € | 9 |
